Pediatric Dermatology

Latest News

Johnson & Johnson Submits 2 sBLAs for Guselkumab for Pediatric Psoriasis and Juvenile PsA
Johnson & Johnson Submits 2 sBLAs for Guselkumab for Pediatric Psoriasis and Juvenile PsA

December 2nd 2024

If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.

Pediatric Melanoma in Review: Providing Considerations for Dermatologists
Pediatric Melanoma in Review: Providing Considerations for Dermatologists

November 22nd 2024

Shanna Miranti, MPAS, PA-C, Shares Expert Acne and Pediatric Dermatology Insights
Shanna Miranti, MPAS, PA-C, Shares Expert Acne and Pediatric Dermatology Insights

November 17th 2024

Off-Treatment Remission Achieved with Dupilumab for Pediatric AD
Off-Treatment Remission Achieved with Dupilumab for Pediatric AD

November 4th 2024

Elimination Diets Have Little Impact on Pediatric Atopic Dermatitis, New Study Finds
Elimination Diets Have Little Impact on Pediatric Atopic Dermatitis, New Study Finds

October 24th 2024

Latest CME Events & Activities

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

View More

Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis

View More

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making

View More

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

View More

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

View More

More News

© 2024 MJH Life Sciences

All rights reserved.